Literature DB >> 1017710

Effect of intraluminal oxygen on experimental ischaemia of the intestine.

K Shute.   

Abstract

The small bowel of 44 rats has been made ischaemic for 120 minutes by occluding the superior mesenteric artery. Gaseous oxygen was introduced into the small bowel lumen of 18 of the rats, and gaseous nitrogen into the bowel lumen of a further eight, 30 minutes after the start of the ischaemia. The mortality rate of the control group of 18 rats was 89%, significantly higher than the 39% mortality of the oxygen-treated rats (p less than 0-005). None of the eight rats treated with intraluminal nitrogen survived. Histological changes caused by ischaemia were much reduced in the intestine of the oxygen treated rats. It is suggested that intraluminal oxygen might be useful additional form of therapy for the treatment of the partially ischaemic bowel that may be retained after the resection of definitely non-viable ischaemic bowel at initial laparotomy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1017710      PMCID: PMC1411228          DOI: 10.1136/gut.17.12.1001

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  QUANTITATION AND IDENTIFICATION OF VASOACTIVE SUBSTANCES LIBERATED DURING VARIOUS TYPES OF EXPERIMENTAL AND CLINICAL INTESTINAL ISCHEMIA.

Authors:  E E KOBOLD; A P THAL
Journal:  Surg Gynecol Obstet       Date:  1963-09

2.  CAUSES OF DEATH IN MESENTERIC ARTERIAL OCCLUSION. I. LOCAL AND GENERAL EFFECTS OF DEVASCULARIZATION OF THE BOWEL.

Authors:  A MARSTON
Journal:  Ann Surg       Date:  1963-12       Impact factor: 12.969

3.  METABOLIC AND FUNCTIONAL CHANGES IN THE INTESTINE IN SHOCK.

Authors:  F N GURD
Journal:  Am J Surg       Date:  1965-09       Impact factor: 2.565

4.  A STUDY OF THE FACTORS INVOLVED IN THE DEVELOPMENT OF PERIPHERAL VASCULAR COLLAPSE FOLLOWING RELEASE OF THE OCCLUDED SUPERIOR MESENTERIC ARTERY.

Authors:  J MILLIKEN; A NAHOR; J FINE
Journal:  Br J Surg       Date:  1965-09       Impact factor: 6.939

5.  ABOLITION OF 'TRYPTIC ENTERITIS' IN THE SHOCKED DOG. CREATION OF AN EXPERIMENTAL MODEL FOR STUDY OF HUMAN SHOCK AND ITS SEQUELAE.

Authors:  G BOUNOUS; R A BROWN; D S MULDER; L G HAMPSON; F N GURD
Journal:  Arch Surg       Date:  1965-09

6.  The intestinal factor in irreversible endotoxin shock.

Authors:  R C LILLEHEI; L D MACLEAN
Journal:  Ann Surg       Date:  1958-10       Impact factor: 12.969

7.  Host resistance to hemorrhagic shock. XI. Role of deficient flow through intestine in development of irreversibility.

Authors:  P B SHAPIRO; B BRONSTHER; E D FRANK; J FINE
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

Review 8.  An aggressive roentgenologic and surgical approach to acute mesenteric ischemia.

Authors:  S J Boley; S Sprayregen; F J Veith; S S Siegelman
Journal:  Surg Annu       Date:  1973

9.  Clinical features of ischemic bowel disease.

Authors:  H Haddad
Journal:  Can J Surg       Date:  1974-11       Impact factor: 2.089

10.  Mesenteric vascular disease.

Authors:  D B Skinner; C K Zarins; A R Moossa
Journal:  Am J Surg       Date:  1974-12       Impact factor: 2.565

View more
  4 in total

Review 1.  Response of the intestinal mucosa to ischaemia.

Authors:  J W Robinson; V Mirkovitch; B Winistörfer; F Saegesser
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

Review 2.  Splanchnic ischaemia and multiple organ failure in the critically ill.

Authors:  R G Fiddian-Green
Journal:  Ann R Coll Surg Engl       Date:  1988-05       Impact factor: 1.891

3.  Free radical formation during splanchnic artery occlusion shock.

Authors:  A Sakamoto; S T Ohnishi; T Ohnishi; R Ogawa
Journal:  J Anesth       Date:  1992-10       Impact factor: 2.078

4.  Protective effect of hyperbaric oxygen treatment on rat intestinal mucosa after mesenteric ischaemia and reperfusion.

Authors:  Kurtuluş Açiksari; Seracettin Eğin; Gülçin Hepgül; Bengüsu Mirasoğlu; Gamze Tanriverdi; Devrim S Kanber; Sibel Demirci; Halil Doğan; Doğaç N Özüçelik; Akın S Toklu; İsmail Seçkin; Hakan T Yanar
Journal:  Diving Hyperb Med       Date:  2019-12-20       Impact factor: 0.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.